Basal Ganglia Pathophysiology
1 – 10 of 189
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Models and biomarkers of motor and neuropsychiatric complications in Parkinson’s disease
2023) In Lund University, Faculty of Medicine Doctoral Dissertation Series(
- Thesis › Doctoral thesis (compilation)
-
Mark
Pregnenolone for the treatment of L-DOPA-induced dyskinesia in Parkinson's disease
(
- Contribution to journal › Article
-
Mark
Comparison of dyskinesia profiles after L-DOPA dose challenges with or without dopamine agonist coadministration
(
- Contribution to journal › Article
-
Mark
Dopamine Agonist Cotreatment Alters Neuroplasticity and Pharmacology of Levodopa-Induced Dyskinesia
(
- Contribution to journal › Article
-
Mark
Ropinirole Cotreatment Prevents Perivascular Glial Recruitment in a Rat Model of L-DOPA-Induced Dyskinesia
(
- Contribution to journal › Article
- 2022
-
Mark
Non-dopaminergic approaches to the treatment of motor complications in Parkinson's disease
(
- Contribution to journal › Scientific review
-
Mark
Sequential or Simultaneous Injection of Preformed Fibrils and AAV Overexpression of Alpha-Synuclein Are Equipotent in Producing Relevant Pathology and Behavioral Deficits
(
- Contribution to journal › Article
-
Mark
Restoring myocardial infarction-induced long-term memory impairment by targeting the cystic fibrosis transmembrane regulator
(
- Contribution to journal › Article
-
Mark
Distinctive Effects of D1 and D2 Receptor Agonists on Cortico-Basal Ganglia Oscillations in a Rodent Model of L-DOPA-Induced Dyskinesia
2022) In Neurotherapeutics(
- Contribution to journal › Article
-
Mark
Verification of multi-structure targeting in chronic microelectrode brain recordings from CT scans
(
- Contribution to journal › Article